Omar Perbellini, MD

UOC Ematologia, Azienda ULSS 8 Berica, Italy

Poster(s):

• 1709 - Impact of Dose Intensity of Ibrutinib on Clinical Outcomes of CLL Patients: Analysis of the EVIdeNCE Study